falsefalse

Treatment and Management of Lung Large Cell Neuroendocrine Carcinoma (LCNEC) - Episode 2

An Overview of the Molecular Characterization of Lung LCNEC

,

Panelists discuss how the characterization and classification of lung large cell neuroendocrine carcinoma (LCNEC) has evolved over the past decade, highlighting the clinical heterogeneity of these tumors and how it is navigated in clinical practice.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    EP. 1: Lung Large Cell Neuroendocrine Carcinoma: A Rare but Aggressive Disease Intro
    Now Viewing
    EP. 2: An Overview of the Molecular Characterization of Lung LCNEC
    EP. 3: The Pathological Diagnosis of Lung LCNEC
    EP. 4: Biomarker Testing Strategies for Lung LCNEC
    EP. 5: Biopsy Best Practices: Diagnosing Lung LCNEC
    EP. 6: Lung LCNEC Diagnostic Challenges
    EP. 7: A Multidisciplinary Approach to Managing Lung LCNEC
    EP. 8: Lung LCNEC Disease Histology and Prognosis
    EP. 9: The Role of DLL3 in LCNEC of the Lung
    EP. 10: Insights on the LANCE Pilot Study on Lung LCNEC
    EP. 11: Novel Targeted Therapies for LCNEC of the Lung
    EP. 12: Overview of Studies of BI 764532 for Lung LCNEC
    EP. 13: Insights Into Ongoing Investigational Studies in Lung LCNEC
    EP. 14: Potential Next-Generation Therapies for Lung LCNEC
    EP. 15: Unmet Needs in LCNEC
    1. Dr. Dietrich to Dr. Yang:
    • How has the characterization and classification of lung LCNEC evolved in the past decade?
    • Can you describe the clinical heterogeneity of these tumors?
    • How do you navigate this in practice?

    Related Content:

    Treatment and Management of Lung Large Cell Neuroendocrine Carcinoma (LCNEC)
    Unmet Needs in LCNEC
    Potential Next-Generation Therapies for Lung LCNEC
    Insights Into Ongoing Investigational Studies in Lung LCNEC
    x